VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
giomer varnish
Preclinical
Small molecule
O
October University for Modern Sciences and Arts
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
White Spot Lesions
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
White Spot Lesions
Preclinical
Completed
Clinical
Trials by Indication
[1]
White Spot Lesions
1 trial
Evaluation of Two Varnishes on the Improvement of White Spot Lesions in Children
Completed
·
O
October University for Modern Sciences and Arts
·
N/A
·
NCT05775250
·
22 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for giomer varnish. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
giomer varnish compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for giomer varnish. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
October University for Modern Sciences and Arts company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
O
October University for Modern Sciences and Arts
Related News